Halkias Theodore 4
4 · agilon health, inc. · Filed Jan 3, 2022
Insider Transaction Report
Form 4
Halkias Theodore
Chief Business Officer
Transactions
- Exercise/Conversion
Common Stock
2021-12-30$1.00/sh+12,113$12,113→ 17,547 total - Sale
Common Stock
2021-12-30$27.54/sh−12,113$333,592→ 5,434 total - Exercise/Conversion
Options (Rights to Buy)
2021-12-30−12,113→ 1,702,609 totalExercise: $1.00Exp: 2027-04-27→ Common Stock (12,113 underlying) - Exercise/Conversion
Options (Rights to Buy)
2021-12-31−1,162→ 1,701,447 totalExercise: $1.00Exp: 2027-04-27→ Common Stock (1,162 underlying) - Exercise/Conversion
Common Stock
2021-12-31$1.00/sh+1,162$1,162→ 6,596 total - Sale
Common Stock
2021-12-31$27.55/sh−1,162$32,013→ 5,434 total
Footnotes (5)
- [F1]Includes restricted stock units.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, which was adopted prior to September 7, 2021.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $27.50 to $27.64, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $27.50 to $27.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F5]These options were granted on April 27, 2017 and vested in four equal installments on May 15th of each of 2018, 2019, 2020, and 2021.